QUEBEC CITY, July 3 /CNW Telbec/ - Advitech Inc. (“Advitech” or the “Company”) (TSX Venture Exchange: AVI) announces today positive results from its clinical trials on psoriasis, eczema and pre-clinical program on wound healing.
QUEBEC CITY, July 3 /CNW Telbec/ - Advitech Inc. (“Advitech” or the “Company”) (TSX Venture Exchange: AVI) announces today positive results from its clinical trials on psoriasis, eczema and pre-clinical program on wound healing.
